News
Dana-Farber researchers have provided the mechanistic and preclinical evidence needed to support a clinical trial of a new ...
Initial analysis identified expected findings (eg, outlier overexpression of CDK4 in 39%-66% of WD-LPSs/DD-LPSs), clinical correlates of fundamental scientific work (eg, CCND1 in 29% of Ewing sarcomas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback